What Questions Should You Ask Before Choosing a Stem Cell Clinic?

What this article covers
- Start With the Single Most Important Question: Is This FDA-Approved or a Registered Trial?
- S. today, and they are overwhelmingly blood-forming (hematopoietic) stem cell products used for specific blood cancers and disorders — not the injectable "stem cell therapy" offered for joint pain, autoimmune conditions, or anti-aging at many private clinics.
- Ask About the Cells Themselves
- " Minimally manipulated, same-day procedures using a patient's own cells face a different regulatory bar than products that are expanded, combined with other substances, or used for a purpose unrelated to their normal function — and that distinction is central to whether a treatment is legally marketed. A clinic that can't or won't explain this clearly is a warning sign.
- Ask About the Physician's Training and the Evidence Base
- Ask what specific training and licensing the treating physician has in regenerative medicine, and ask to see published, peer-reviewed evidence for your specific condition — not just patient testimonials or before-and-after photos. Reputable centers acknowledge the limits of current evidence and can point to specific studies with real patient numbers.
- Red Flags Worth Walking Away From
- Several warning signs come up consistently across FDA guidance and academic patient-safety resources: claims of "100% success" or guaranteed results; treatment offered for conditions the FDA has specifically flagged as targets of deceptive marketing, including autism, COVID-19 complications, and various neurological, cardiac, and orthopedic conditions with no approved stem cell treatment; a clinic that won't disclose its cell source or processing method; pressure to pay upfront for a treatment described as "not yet insurance-covered because it's cutting-edge" rather than because it isn't approved; and the absence of a real informed-consent document explaining specific risks. The FDA has documented serious harms from unapproved regenerative products, including blindness, infections, tumor formation, and dangerous immune reactions — real risks, not theoretical ones.
- Ask About Safety, Cost, and What Happens If Something Goes Wrong
- Before treatment, ask what specific adverse reactions are possible, whether the treatment requires immunosuppression or hospitalization, whether repeat treatments are typically needed, what the full cost is including any follow-up care, and what recourse exists if you're harmed. Ask, too, what alternative — including standard, insurance-covered — treatments exist for your condition, and why the clinic believes this option is preferable.
The gap between what's FDA-approved and what's marketed as "stem cell therapy" in the U.S. is wide — and it's the single biggest source of patient risk in this field. This article lays out the specific questions patients and caregivers should ask before agreeing to any stem cell treatment, drawn from FDA consumer guidance, an academic stem cell therapy center's pre-treatment checklist, and a national patient-safety resource, so readers can walk into a consultation prepared rather than persuaded.
Start With the Single Most Important Question: Is This FDA-Approved or a Registered Trial?
Only a small number of stem cell products are FDA-approved in the U.S. today, and they are overwhelmingly blood-forming (hematopoietic) stem cell products used for specific blood cancers and disorders — not the injectable "stem cell therapy" offered for joint pain, autoimmune conditions, or anti-aging at many private clinics. If a clinic is offering something else, ask directly: is this treatment FDA-approved for my condition, or is it part of an FDA-overseen clinical trial? The FDA has been explicit on this point: simply appearing in the ClinicalTrials.gov database, or a firm being "registered" with the FDA, does not mean a product is legally marketed or has been reviewed for safety and effectiveness. Ask the clinic to show you exactly where their treatment falls on that spectrum, and verify it yourself before proceeding.
Ask About the Cells Themselves
A legitimate provider should be able to answer, in specific terms, three things: what tissue the cells come from (your own bone marrow or fat tissue, or a donor source like umbilical cord tissue), what processing the cells undergo between collection and injection, and whether that processing goes beyond what regulators classify as "minimal manipulation." Minimally manipulated, same-day procedures using a patient's own cells face a different regulatory bar than products that are expanded, combined with other substances, or used for a purpose unrelated to their normal function — and that distinction is central to whether a treatment is legally marketed. A clinic that can't or won't explain this clearly is a warning sign.
Ask About the Physician's Training and the Evidence Base
Ask what specific training and licensing the treating physician has in regenerative medicine, and ask to see published, peer-reviewed evidence for your specific condition — not just patient testimonials or before-and-after photos. Reputable centers acknowledge the limits of current evidence and can point to specific studies with real patient numbers. Testimonials alone, however compelling, are not evidence, and academic stem cell centers explicitly warn patients to request data beyond them.
Red Flags Worth Walking Away From
Several warning signs come up consistently across FDA guidance and academic patient-safety resources: claims of "100% success" or guaranteed results; treatment offered for conditions the FDA has specifically flagged as targets of deceptive marketing, including autism, COVID-19 complications, and various neurological, cardiac, and orthopedic conditions with no approved stem cell treatment; a clinic that won't disclose its cell source or processing method; pressure to pay upfront for a treatment described as "not yet insurance-covered because it's cutting-edge" rather than because it isn't approved; and the absence of a real informed-consent document explaining specific risks. The FDA has documented serious harms from unapproved regenerative products, including blindness, infections, tumor formation, and dangerous immune reactions — real risks, not theoretical ones.
Ask About Safety, Cost, and What Happens If Something Goes Wrong
Before treatment, ask what specific adverse reactions are possible, whether the treatment requires immunosuppression or hospitalization, whether repeat treatments are typically needed, what the full cost is including any follow-up care, and what recourse exists if you're harmed. Ask, too, what alternative — including standard, insurance-covered — treatments exist for your condition, and why the clinic believes this option is preferable.
Verify Independently Before You Commit
Don't rely solely on what the clinic tells you. Search ClinicalTrials.gov directly for the treatment and confirm it's an actively registered, IRB-overseen trial if that's the claim being made. If you have concerns about a specific clinic or want to verify a treatment's status, the FDA's Office of Combination Products can be reached at ocod@fda.hhs.gov, and any adverse event after treatment should be reported through the FDA's MedWatch program. These are free, publicly available checks that take a fraction of the time — and cost — of the treatment itself.
Bottom Line
The honest, evidence-based version of this advice isn't "avoid stem cell therapy" — regulated, FDA-approved stem cell treatments and legitimate clinical trials genuinely help patients every year, and this site covers many of them. The advice is to ask pointed questions before you pay: what's the regulatory status, what exactly is being injected, what's the physician's evidence, and can you independently verify any of it. A clinic confident in its offering will welcome those questions. One that deflects them is telling you something important.
Key Questions Answered
- How can I tell if a stem cell treatment is legitimate or FDA-approved?
- You should ask the clinic directly if the treatment is FDA-approved for your specific condition or if it is part of an FDA-overseen clinical trial. Most FDA-approved stem cell products are blood-forming (hematopoietic) stem cells used for specific blood cancers and disorders, not for conditions like joint pain or autoimmune issues. Appearing in ClinicalTrials.gov or being 'registered' with the FDA does not mean a product is legally marketed or has been reviewed for safety and effectiveness.
- What questions should I ask about the stem cells themselves?
- A legitimate provider should clearly state what tissue the cells come from (e.g., your own bone marrow or fat tissue, or a donor source), what processing the cells undergo between collection and injection, and whether that processing goes beyond 'minimal manipulation.' This distinction is crucial for determining if a treatment is legally marketed, as products that are expanded or combined with other substances face different regulatory requirements.
- What are some red flags to look out for when considering a stem cell clinic?
- Warning signs include claims of '100% success' or guaranteed results, offering treatment for conditions the FDA has specifically flagged as targets of deceptive marketing, or a clinic that won't disclose its cell source or processing method. Other red flags are pressure to pay upfront for 'cutting-edge' treatment not covered by insurance and the absence of a real informed-consent document explaining specific risks. The FDA has documented serious harms from unapproved products, such as blindness, infections, and tumor formation.
- What should I ask about a physician's training and the evidence supporting a stem cell treatment?
- You should ask about the specific training and licensing the treating physician has in regenerative medicine. Additionally, request to see published, peer-reviewed evidence for your specific condition, rather than relying solely on patient testimonials or before-and-after photos. Reputable centers acknowledge current evidence limits and can point to specific studies with patient numbers, as testimonials alone are not considered evidence.
Sources
- Important Patient and Consumer Information About Regenerative Medicine Therapies, U.S. Food and Drug Administration, updated 2024, https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies
- Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes, U.S. Food and Drug Administration, https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes
- What to Know Before Treatment, Midwest Stem Cell Therapy Center, University of Kansas Medical Center, https://www.kumc.edu/research/midwest-stem-cell-therapy-center/stem-cell-information/what-to-know-before-treatment.html
- Beware of Stem Cell Clinics, NMDP Clinical Trial Search Support Service, https://www.ctsearchsupport.org/resources/treatments/stem-cell-clinics
- Ethical Issues: Unproven Stem Cell Products, American Society of Gene & Cell Therapy (ASGCT) Patient Education, https://patienteducation.asgct.org/understanding-cell-gene-therapy/ethical-issues-unproven-stem-cell-products
- The ISSCR Guide to Stem Cell Treatments, International Society for Stem Cell Research, https://www.isscr.org/treatment-guide
- FDA Warns About Stem Cell Therapies, U.S. Food and Drug Administration, https://cacmap.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies
Related Articles
- Research & Industry
ISSCR 2027: A Milestone Stem Cell Meeting Comes to San Francisco
ISSCR 2027 meets June 15–18 at San Francisco’s Moscone West, spotlighting stem cell science, AI, bioengineering and cell therapies.
- Research & Industry
What Accreditation and Certifications Actually Mean When Evaluating a Stem Cell Clinic
What AAAHC, Joint Commission and FACT accreditation really checks, what it does not prove, and how to verify clinic claims independently.
- Research & Industry
Stem Cell and Exosome Therapy in the UAE: What's Actually Happening
Dubai’s 2026 stem cell rules tighten licensing and limit routine care to minimally manipulated autologous cells, while exosome products remain a regulatory gap.